Poor ovarian reserve (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Poor ovarian reserve" in English language version.

refsWebsite

Global rank English rank

36nih.gov

4^th place

29doi.org

2^nd place

7semanticscholar.org

11^th place

8^th place

3handle.net

102^nd place

76^th place

2web.archive.org

1^st place

1fertstert.org

low place

1arxiv.org

69^th place

59^th place

1harvard.edu

18^th place

17^th place

1loc.gov

70^th place

63^rd place

1fragilex.org

low place

1cdc.gov

218^th place

212^th place

1archive.org

6^th place

1infertile.com

low place

1eur.nl

low place

9,966^th place

1fertell.com

low place

1newhopefertility.com

low place

archive.org

Silber SJ (2005). How to Get Pregnant. New York: Little Brown and Company. ISBN 978-0-316-06650-1.

arxiv.org

Wallace WH, Kelsey TW (January 2010). "Human ovarian reserve from conception to the menopause". PLOS ONE. 5 (1): e8772. arXiv:1106.1382. Bibcode:2010PLoSO...5.8772W. doi:10.1371/journal.pone.0008772. PMC 2811725. PMID 20111701.

cdc.gov

"Assisted Reproduction Technology". Centers for Disease Control and Prevention. U.S. Department of Health & Human Services. 17 December 2021.

doi.org

Gleicher N, Weghofer A, Oktay K, Barad D (October 2009). "Do etiologies of premature ovarian aging (POA) mimic those of premature ovarian failure (POF)?". Human Reproduction. 24 (10): 2395–2400. doi:10.1093/humrep/dep256. PMID 19617205.
Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z (April 1989). "Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome". Fertility and Sterility. 51 (4): 651–654. doi:10.1016/S0015-0282(16)60615-5. PMID 2494082.
Thum MY, Abdalla HI, Taylor D (August 2008). "Relationship between women's age and basal follicle-stimulating hormone levels with aneuploidy risk in in vitro fertilization treatment". Fertility and Sterility. 90 (2): 315–321. doi:10.1016/j.fertnstert.2007.06.063. PMID 17953958.
Abdalla H, Thum MY (April 2004). "An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve". Human Reproduction. 19 (4): 893–898. doi:10.1093/humrep/deh141. PMID 15016786.
Rosen MP, Shen S, Huddleston HG, Fujimoto VY, Cedars MI (September 2008). "What is diminished ovarian reserve (DOR) – reduced quantity vs. reduced quality?". Fertil. Steril. 90 (Supplement): S258. doi:10.1016/j.fertnstert.2008.07.1283.
Toner JP (March 2003). "Age = egg quality, FSH level = egg quantity". Fertility and Sterility. 79 (3): 491. doi:10.1016/S0015-0282(02)04840-9. PMID 12620427.
Wallace WH, Kelsey TW (January 2010). "Human ovarian reserve from conception to the menopause". PLOS ONE. 5 (1): e8772. arXiv:1106.1382. Bibcode:2010PLoSO...5.8772W. doi:10.1371/journal.pone.0008772. PMC 2811725. PMID 20111701.
Seow KM, Juan CC, Hwang JL, Ho LT (January 2008). "Laparoscopic surgery in polycystic ovary syndrome: reproductive and metabolic effects". Seminars in Reproductive Medicine. 26 (1): 101–110. doi:10.1055/s-2007-992930. PMID 18181088. S2CID 260316693.
Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB (2006). "A systematic review of tests predicting ovarian reserve and IVF outcome". Human Reproduction Update. 12 (6): 685–718. doi:10.1093/humupd/dml034. PMID 16891297.
Navot D, Rosenwaks Z, Margalioth EJ (September 1987). "Prognostic assessment of female fecundity". Lancet. 2 (8560): 645–647. doi:10.1016/s0140-6736(87)92439-1. PMID 2887939. S2CID 13959528.
Klinkert ER, Broekmans FJ, Looman CW, Habbema JD, te Velde ER (March 2005). "The antral follicle count is a better marker than basal follicle-stimulating hormone for the selection of older patients with acceptable pregnancy prospects after in vitro fertilization". Fertility and Sterility. 83 (3): 811–814. doi:10.1016/j.fertnstert.2004.11.005. hdl:1874/10690. PMID 15749527. S2CID 44442128.
Broekmans FJ, Faddy MJ, Scheffer G, te Velde ER (2004). "Antral follicle counts are related to age at natural fertility loss and age at menopause". Menopause. 11 (6 Pt 1): 607–614. doi:10.1097/01.gme.0000123643.76105.27. hdl:1874/10681. PMID 15545788. S2CID 23142876.
van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, et al. (April 2005). "Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study". Fertility and Sterility. 83 (4): 979–987. doi:10.1016/j.fertnstert.2004.11.029. hdl:1765/73139. PMID 15820810. S2CID 2579891.
Lass A, Brinsden P (1999). "The role of ovarian volume in reproductive medicine". Human Reproduction Update. 5 (3): 256–266. doi:10.1093/humupd/5.3.256. PMID 10438110.
Sauer MV, Paulson RJ, Lobo RA (July 1995). "Pregnancy in women 50 or more years of age: outcomes of 22 consecutively established pregnancies from oocyte donation". Fertility and Sterility. 64 (1): 111–115. doi:10.1016/S0015-0282(16)57665-1. PMID 7789544.
Tartagni M, Cicinelli E, De Pergola G, De Salvia MA, Lavopa C, Loverro G (April 2007). "Effects of pretreatment with estrogens on ovarian stimulation with gonadotropins in women with premature ovarian failure: a randomized, placebo-controlled trial". Fertility and Sterility. 87 (4): 858–861. doi:10.1016/j.fertnstert.2006.08.086. PMID 17261285.
Check JH, Check ML, Katsoff D (August 2000). "Three pregnancies despite elevated serum FSH and advanced age: case report". Human Reproduction. 15 (8): 1709–1712. doi:10.1093/humrep/15.8.1709. PMID 10920090.
Check JH (December 2007). "Mild ovarian stimulation". Journal of Assisted Reproduction and Genetics. 24 (12): 621–627. doi:10.1007/s10815-007-9179-9. PMC 3454994. PMID 18058016.
Dragojević-Dikić S, Rakić S, Nikolić B, Popovac S (December 2009). "Hormone replacement therapy and successful pregnancy in a patient with premature ovarian failure". Gynecological Endocrinology. 25 (12): 769–772. doi:10.3109/09513590903004126. PMID 19905994. S2CID 32319689.
Loutradis D, Drakakis P, Vomvolaki E, Antsaklis A (December 2007). "Different ovarian stimulation protocols for women with diminished ovarian reserve". Journal of Assisted Reproduction and Genetics. 24 (12): 597–611. doi:10.1007/s10815-007-9181-2. PMC 3455002. PMID 18034299.
Fisch JD, Keskintepe L, Sher G (February 2008). "Gonadotropin-releasing hormone agonist/antagonist conversion with estrogen priming in low responders with prior in vitro fertilization failure". Fertility and Sterility. 89 (2): 342–347. doi:10.1016/j.fertnstert.2007.03.004. PMID 17562336.
Barad D, Gleicher N (November 2006). "Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF". Human Reproduction. 21 (11): 2845–2849. doi:10.1093/humrep/del254. PMID 16997936.
Barad DH, Gleicher N (September 2005). "Increased oocyte production after treatment with dehydroepiandrosterone". Fertility and Sterility. 84 (3): 756.e1–756.e3. doi:10.1016/j.fertnstert.2005.02.049. PMID 16169414.
Mamas L, Mamas E (February 2009). "Premature ovarian failure and dehydroepiandrosterone". Fertility and Sterility. 91 (2): 644–646. doi:10.1016/j.fertnstert.2007.11.055. PMID 18321501.
Gleicher N, Ryan E, Weghofer A, Blanco-Mejia S, Barad DH (October 2009). "Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study". Reproductive Biology and Endocrinology. 7: 108. doi:10.1186/1477-7827-7-108. PMC 2764711. PMID 19811650.
Letur-Konirsch H, Delanian S (February 2003). "Successful pregnancies after combined pentoxifylline-tocopherol treatment in women with premature ovarian failure who are resistant to hormone replacement therapy". Fertility and Sterility. 79 (2): 439–441. doi:10.1016/S0015-0282(02)04579-X. PMID 12568863.
Letur-Könirsch H, Guis F, Delanian S (June 2002). "Uterine restoration by radiation sequelae regression with combined pentoxifylline-tocopherol: a phase II study". Fertility and Sterility. 77 (6): 1219–1226. doi:10.1016/s0015-0282(02)03120-5. PMID 12057732.
Lédée-Bataille N, Olivennes F, Lefaix JL, Chaouat G, Frydman R, Delanian S (May 2002). "Combined treatment by pentoxifylline and tocopherol for recipient women with a thin endometrium enrolled in an oocyte donation programme". Human Reproduction. 17 (5): 1249–1253. doi:10.1093/humrep/17.5.1249. PMID 11980747.
Brann DW, Mahesh VB (April 2005). "The aging reproductive neuroendocrine axis". Steroids. 70 (4): 273–283. doi:10.1016/j.steroids.2004.12.008. PMID 16080236. S2CID 54300307.

eur.nl

repub.eur.nl

van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, et al. (April 2005). "Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study". Fertility and Sterility. 83 (4): 979–987. doi:10.1016/j.fertnstert.2004.11.029. hdl:1765/73139. PMID 15820810. S2CID 2579891.

fertell.com

hcp.fertell.com

"Fertell Clinical Results". Fertell.com. Archived from the original on 2 February 2007.

fertstert.org

Rosen MP, Shen S, Huddleston HG, Fujimoto VY, Cedars MI (September 2008). "What is diminished ovarian reserve (DOR) – reduced quantity vs. reduced quality?". Fertil. Steril. 90 (Supplement): S258. doi:10.1016/j.fertnstert.2008.07.1283.

fragilex.org

"Facts about Primary Ovarian Insufficiency (POI)". The National Fragile X Foundation. Archived from the original on 2008-11-06.

handle.net

hdl.handle.net

Klinkert ER, Broekmans FJ, Looman CW, Habbema JD, te Velde ER (March 2005). "The antral follicle count is a better marker than basal follicle-stimulating hormone for the selection of older patients with acceptable pregnancy prospects after in vitro fertilization". Fertility and Sterility. 83 (3): 811–814. doi:10.1016/j.fertnstert.2004.11.005. hdl:1874/10690. PMID 15749527. S2CID 44442128.
Broekmans FJ, Faddy MJ, Scheffer G, te Velde ER (2004). "Antral follicle counts are related to age at natural fertility loss and age at menopause". Menopause. 11 (6 Pt 1): 607–614. doi:10.1097/01.gme.0000123643.76105.27. hdl:1874/10681. PMID 15545788. S2CID 23142876.
van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, et al. (April 2005). "Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study". Fertility and Sterility. 83 (4): 979–987. doi:10.1016/j.fertnstert.2004.11.029. hdl:1765/73139. PMID 15820810. S2CID 2579891.

harvard.edu

ui.adsabs.harvard.edu

Wallace WH, Kelsey TW (January 2010). "Human ovarian reserve from conception to the menopause". PLOS ONE. 5 (1): e8772. arXiv:1106.1382. Bibcode:2010PLoSO...5.8772W. doi:10.1371/journal.pone.0008772. PMC 2811725. PMID 20111701.

infertile.com

Silber SJ (2006). "Treating Infertility" (PDF). St. Louis, Missouri: Infertility Center of St. Louis.

loc.gov

webarchive.loc.gov

"Facts about Primary Ovarian Insufficiency (POI)". The National Fragile X Foundation. Archived from the original on 2008-11-06.

newhopefertility.com

"IVF Message Boards". www.newhopefertility.com. Archived from the original on 2008-03-12.

nih.gov

pubmed.ncbi.nlm.nih.gov

Gleicher N, Weghofer A, Oktay K, Barad D (October 2009). "Do etiologies of premature ovarian aging (POA) mimic those of premature ovarian failure (POF)?". Human Reproduction. 24 (10): 2395–2400. doi:10.1093/humrep/dep256. PMID 19617205.
Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z (April 1989). "Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome". Fertility and Sterility. 51 (4): 651–654. doi:10.1016/S0015-0282(16)60615-5. PMID 2494082.
Thum MY, Abdalla HI, Taylor D (August 2008). "Relationship between women's age and basal follicle-stimulating hormone levels with aneuploidy risk in in vitro fertilization treatment". Fertility and Sterility. 90 (2): 315–321. doi:10.1016/j.fertnstert.2007.06.063. PMID 17953958.
Abdalla H, Thum MY (April 2004). "An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve". Human Reproduction. 19 (4): 893–898. doi:10.1093/humrep/deh141. PMID 15016786.
Toner JP (March 2003). "Age = egg quality, FSH level = egg quantity". Fertility and Sterility. 79 (3): 491. doi:10.1016/S0015-0282(02)04840-9. PMID 12620427.
Wallace WH, Kelsey TW (January 2010). "Human ovarian reserve from conception to the menopause". PLOS ONE. 5 (1): e8772. arXiv:1106.1382. Bibcode:2010PLoSO...5.8772W. doi:10.1371/journal.pone.0008772. PMC 2811725. PMID 20111701.
Seow KM, Juan CC, Hwang JL, Ho LT (January 2008). "Laparoscopic surgery in polycystic ovary syndrome: reproductive and metabolic effects". Seminars in Reproductive Medicine. 26 (1): 101–110. doi:10.1055/s-2007-992930. PMID 18181088. S2CID 260316693.
Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB (2006). "A systematic review of tests predicting ovarian reserve and IVF outcome". Human Reproduction Update. 12 (6): 685–718. doi:10.1093/humupd/dml034. PMID 16891297.
Navot D, Rosenwaks Z, Margalioth EJ (September 1987). "Prognostic assessment of female fecundity". Lancet. 2 (8560): 645–647. doi:10.1016/s0140-6736(87)92439-1. PMID 2887939. S2CID 13959528.
Klinkert ER, Broekmans FJ, Looman CW, Habbema JD, te Velde ER (March 2005). "The antral follicle count is a better marker than basal follicle-stimulating hormone for the selection of older patients with acceptable pregnancy prospects after in vitro fertilization". Fertility and Sterility. 83 (3): 811–814. doi:10.1016/j.fertnstert.2004.11.005. hdl:1874/10690. PMID 15749527. S2CID 44442128.
Broekmans FJ, Faddy MJ, Scheffer G, te Velde ER (2004). "Antral follicle counts are related to age at natural fertility loss and age at menopause". Menopause. 11 (6 Pt 1): 607–614. doi:10.1097/01.gme.0000123643.76105.27. hdl:1874/10681. PMID 15545788. S2CID 23142876.
van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, et al. (April 2005). "Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study". Fertility and Sterility. 83 (4): 979–987. doi:10.1016/j.fertnstert.2004.11.029. hdl:1765/73139. PMID 15820810. S2CID 2579891.
Lass A, Brinsden P (1999). "The role of ovarian volume in reproductive medicine". Human Reproduction Update. 5 (3): 256–266. doi:10.1093/humupd/5.3.256. PMID 10438110.
Sauer MV, Paulson RJ, Lobo RA (July 1995). "Pregnancy in women 50 or more years of age: outcomes of 22 consecutively established pregnancies from oocyte donation". Fertility and Sterility. 64 (1): 111–115. doi:10.1016/S0015-0282(16)57665-1. PMID 7789544.
Tartagni M, Cicinelli E, De Pergola G, De Salvia MA, Lavopa C, Loverro G (April 2007). "Effects of pretreatment with estrogens on ovarian stimulation with gonadotropins in women with premature ovarian failure: a randomized, placebo-controlled trial". Fertility and Sterility. 87 (4): 858–861. doi:10.1016/j.fertnstert.2006.08.086. PMID 17261285.
Check JH, Check ML, Katsoff D (August 2000). "Three pregnancies despite elevated serum FSH and advanced age: case report". Human Reproduction. 15 (8): 1709–1712. doi:10.1093/humrep/15.8.1709. PMID 10920090.
Check ML, Check JH, Choe JK, Berger GS (2002). "Successful pregnancy in a 42-year-old woman with imminent ovarian failure following ovulation induction with ethinyl estradiol without gonadotropins and in vitro fertilization". Clinical and Experimental Obstetrics & Gynecology. 29 (1): 11–14. PMID 12013081.
Check ML, Check JH, Kaplan H (2004). "Pregnancy despite imminent ovarian failure and extremely high endogenous gonadotropins and therapeutic strategies: case report and review". Clinical and Experimental Obstetrics & Gynecology. 31 (4): 299–301. PMID 15672973.
Katsoff B, Check JH (2005). "Successful pregnancy in a 45-year-old woman with elevated day 3 serum follicle stimulating hormone and a short follicular phase". Clinical and Experimental Obstetrics & Gynecology. 32 (2): 97–98. PMID 16108390.
Check JH (2006). "Pharmacological options in resistent[sic] ovary syndrome and premature ovarian failure". Clinical and Experimental Obstetrics & Gynecology. 33 (2): 71–77. PMID 16903240.
Check JH (December 2007). "Mild ovarian stimulation". Journal of Assisted Reproduction and Genetics. 24 (12): 621–627. doi:10.1007/s10815-007-9179-9. PMC 3454994. PMID 18058016.
Dragojević-Dikić S, Rakić S, Nikolić B, Popovac S (December 2009). "Hormone replacement therapy and successful pregnancy in a patient with premature ovarian failure". Gynecological Endocrinology. 25 (12): 769–772. doi:10.3109/09513590903004126. PMID 19905994. S2CID 32319689.
Loutradis D, Drakakis P, Vomvolaki E, Antsaklis A (December 2007). "Different ovarian stimulation protocols for women with diminished ovarian reserve". Journal of Assisted Reproduction and Genetics. 24 (12): 597–611. doi:10.1007/s10815-007-9181-2. PMC 3455002. PMID 18034299.
Fisch JD, Keskintepe L, Sher G (February 2008). "Gonadotropin-releasing hormone agonist/antagonist conversion with estrogen priming in low responders with prior in vitro fertilization failure". Fertility and Sterility. 89 (2): 342–347. doi:10.1016/j.fertnstert.2007.03.004. PMID 17562336.
Barad D, Gleicher N (November 2006). "Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF". Human Reproduction. 21 (11): 2845–2849. doi:10.1093/humrep/del254. PMID 16997936.
Barad DH, Gleicher N (September 2005). "Increased oocyte production after treatment with dehydroepiandrosterone". Fertility and Sterility. 84 (3): 756.e1–756.e3. doi:10.1016/j.fertnstert.2005.02.049. PMID 16169414.
Mamas L, Mamas E (February 2009). "Premature ovarian failure and dehydroepiandrosterone". Fertility and Sterility. 91 (2): 644–646. doi:10.1016/j.fertnstert.2007.11.055. PMID 18321501.
Gleicher N, Ryan E, Weghofer A, Blanco-Mejia S, Barad DH (October 2009). "Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study". Reproductive Biology and Endocrinology. 7: 108. doi:10.1186/1477-7827-7-108. PMC 2764711. PMID 19811650.
Letur-Konirsch H, Delanian S (February 2003). "Successful pregnancies after combined pentoxifylline-tocopherol treatment in women with premature ovarian failure who are resistant to hormone replacement therapy". Fertility and Sterility. 79 (2): 439–441. doi:10.1016/S0015-0282(02)04579-X. PMID 12568863.
Letur-Könirsch H, Guis F, Delanian S (June 2002). "Uterine restoration by radiation sequelae regression with combined pentoxifylline-tocopherol: a phase II study". Fertility and Sterility. 77 (6): 1219–1226. doi:10.1016/s0015-0282(02)03120-5. PMID 12057732.
Lédée-Bataille N, Olivennes F, Lefaix JL, Chaouat G, Frydman R, Delanian S (May 2002). "Combined treatment by pentoxifylline and tocopherol for recipient women with a thin endometrium enrolled in an oocyte donation programme". Human Reproduction. 17 (5): 1249–1253. doi:10.1093/humrep/17.5.1249. PMID 11980747.
Brann DW, Mahesh VB (April 2005). "The aging reproductive neuroendocrine axis". Steroids. 70 (4): 273–283. doi:10.1016/j.steroids.2004.12.008. PMID 16080236. S2CID 54300307.

ncbi.nlm.nih.gov

Wallace WH, Kelsey TW (January 2010). "Human ovarian reserve from conception to the menopause". PLOS ONE. 5 (1): e8772. arXiv:1106.1382. Bibcode:2010PLoSO...5.8772W. doi:10.1371/journal.pone.0008772. PMC 2811725. PMID 20111701.
Check JH (December 2007). "Mild ovarian stimulation". Journal of Assisted Reproduction and Genetics. 24 (12): 621–627. doi:10.1007/s10815-007-9179-9. PMC 3454994. PMID 18058016.
Loutradis D, Drakakis P, Vomvolaki E, Antsaklis A (December 2007). "Different ovarian stimulation protocols for women with diminished ovarian reserve". Journal of Assisted Reproduction and Genetics. 24 (12): 597–611. doi:10.1007/s10815-007-9181-2. PMC 3455002. PMID 18034299.
Gleicher N, Ryan E, Weghofer A, Blanco-Mejia S, Barad DH (October 2009). "Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study". Reproductive Biology and Endocrinology. 7: 108. doi:10.1186/1477-7827-7-108. PMC 2764711. PMID 19811650.

semanticscholar.org

api.semanticscholar.org

Seow KM, Juan CC, Hwang JL, Ho LT (January 2008). "Laparoscopic surgery in polycystic ovary syndrome: reproductive and metabolic effects". Seminars in Reproductive Medicine. 26 (1): 101–110. doi:10.1055/s-2007-992930. PMID 18181088. S2CID 260316693.
Navot D, Rosenwaks Z, Margalioth EJ (September 1987). "Prognostic assessment of female fecundity". Lancet. 2 (8560): 645–647. doi:10.1016/s0140-6736(87)92439-1. PMID 2887939. S2CID 13959528.
Klinkert ER, Broekmans FJ, Looman CW, Habbema JD, te Velde ER (March 2005). "The antral follicle count is a better marker than basal follicle-stimulating hormone for the selection of older patients with acceptable pregnancy prospects after in vitro fertilization". Fertility and Sterility. 83 (3): 811–814. doi:10.1016/j.fertnstert.2004.11.005. hdl:1874/10690. PMID 15749527. S2CID 44442128.
Broekmans FJ, Faddy MJ, Scheffer G, te Velde ER (2004). "Antral follicle counts are related to age at natural fertility loss and age at menopause". Menopause. 11 (6 Pt 1): 607–614. doi:10.1097/01.gme.0000123643.76105.27. hdl:1874/10681. PMID 15545788. S2CID 23142876.
van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, et al. (April 2005). "Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study". Fertility and Sterility. 83 (4): 979–987. doi:10.1016/j.fertnstert.2004.11.029. hdl:1765/73139. PMID 15820810. S2CID 2579891.
Dragojević-Dikić S, Rakić S, Nikolić B, Popovac S (December 2009). "Hormone replacement therapy and successful pregnancy in a patient with premature ovarian failure". Gynecological Endocrinology. 25 (12): 769–772. doi:10.3109/09513590903004126. PMID 19905994. S2CID 32319689.
Brann DW, Mahesh VB (April 2005). "The aging reproductive neuroendocrine axis". Steroids. 70 (4): 273–283. doi:10.1016/j.steroids.2004.12.008. PMID 16080236. S2CID 54300307.

web.archive.org

"Fertell Clinical Results". Fertell.com. Archived from the original on 2 February 2007.
"IVF Message Boards". www.newhopefertility.com. Archived from the original on 2008-03-12.